Improved treatment satisfaction with once-weekly insulin icodec versus once-daily insulin degludec in basal insulin-treated type 2 diabetes (ONWARDS 2)

被引：0
|
作者：
Polonsky, W. [1 ]
Benamar, M. [2 ]
Carstensen, L. [2 ]
Davies, M. [3 ]
Donatsky, A. M. [2 ]
Franek, E. [4 ]
Kellerer, M. [5 ]
Goldenberg, R. [6 ]
机构：
[1] Behav Diabet Inst, San Diego, CA USA
[2] Novo Nordisk AS, Soborg, Denmark
[3] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
[4] Minist Interior, Cent Clin Hosp, Warsaw, Poland
[5] Marien Hosp, Clin Internal Med, Stuttgart, Germany
[6] LMC Diabet & Endocrinol, Concord, ON, Canada
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
780
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [21] No evidence of increased physical activity-related hypoglycaemia with once-weekly insulin icodec vs once-daily basal insulin in type 1 diabetes: ONWARDS 6
    Sourij, H.
    Bracken, R.
    Asong, M.
    Carstensen, L.
    Watt, S. Kehlet
    Philis-Tsimikas, A.
    DIABETOLOGIA, 2024, 67 : S7 - S8
  • [22] No evidence of increased physical activity-related hypoglycaemia with once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes: ONWARDS 1-5
    Riddell, M. C.
    Heller, S.
    Asong, M.
    Carstensen, L.
    Watt, S. Kehlet
    Woo, V. C.
    DIABETOLOGIA, 2024, 67 : S376 - S377
  • [23] Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1
    Polonsky, William
    Benamar, Malik
    Carstensen, Lisbeth
    Davies, Melanie
    Donatsky, Anders Meller
    Franek, Edward
    Kellerer, Monika
    Philis-Tsimikas, Athena
    Goldenberg, Ronald
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 217
  • [24] Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
    Bajaj, Harpreet S.
    Bergenstal, Richard M.
    Christoffersen, Andreas
    Davies, Melanie J.
    Gowda, Amoolya
    Isendahl, Joakim
    Lingvay, Ildiko
    Senior, Peter A.
    Silver, Robert J.
    Trevisan, Roberto
    Rosenstock, Julio
    DIABETES CARE, 2021, 44 (07) : 1586 - 1594
  • [25] Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
    Pieber, T. R.
    Arfelt, K. N.
    Cailleteau, R.
    Thomsen, K. M. Due
    Hart, M.
    Mursic, I.
    Svehlikova, E.
    Urschitz, M.
    Haahr, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S333
  • [26] Once-weekly Insulin Icodec as Compared to Once-daily Basal Insulins: A Meta-analysis
    Mukhopadhyay, Pradip
    Chatterjee, Purushottam
    Pandit, Kaushik
    Sanyal, Debmalya
    Ghosh, Sujoy
    ENDOCRINE PRACTICE, 2024, 30 (02) : 128 - 134
  • [27] Once-weekly Insulin Icodec: An emerging treatment option for type 2 Diabetes
    Zahra, Rubab
    Tariq, Fasiha
    Ahmed, Mushood
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (08) : 1583 - 1583
  • [28] CGM outcomes and hypoglycaemia duration with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-naive type 2 diabetes: ONWARDS 1 exploratory analysis
    Bergenstal, R.
    Watt, S. Kehlet
    Matos, A. S. A.
    Lingvay, I.
    Mader, J. K.
    Nishida, T.
    Rosenstock, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S397
  • [29] CGM-based measurements for once-weekly insulin icodec vs once-daily insulin glargine U100 in insulin-treated patients with type 2 diabetes: a post hoc analysis
    Bajaj, H. S.
    Bang, R. Beck
    Gowda, A.
    Liu, L.
    Senior, P.
    Bergenstal, R.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 266 - 266
  • [30] Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
    Hovelmann, Ulrike
    Brondsted, Lise
    Kristensen, Niels R.
    Ribel-Madsen, Rasmus
    Devries, J. Hans
    Heise, Tim
    Haahr, Hanne
    DIABETES, 2020, 69
12345